AAAAAA

   
Results: 1-7 |
Results: 7
DOSE-TITRATION, MULTICENTER STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE FOR THE TREATMENT OF BREAKTHROUGH PAIN IN CANCER-PATIENTS USING TRANSDERMAL FENTANYL FOR PERSISTENT PAIN
Authors: CHRISTIE JM SIMMONDS M PATT R COLUZZI P BUSCH MA NORDBROCK E PORTENOY RK
Citation: Jm. Christie et al., DOSE-TITRATION, MULTICENTER STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE FOR THE TREATMENT OF BREAKTHROUGH PAIN IN CANCER-PATIENTS USING TRANSDERMAL FENTANYL FOR PERSISTENT PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3238-3245
PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS
Authors: MORGAN RJ NEWMAN EM DOROSHOW JH MCGONIGLE K MARGOLIN K RASCHKO J CHOW W SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V CARROLL M VASILEV S AKMAN S COLUZZI P WAGMAN L LONGMATE J PAZ B YEN Y KLEVECZ R
Citation: Rj. Morgan et al., PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS, Cancer research, 58(13), 1998, pp. 2793-2800
HIGH-DOSE INFUSIONAL DOXORUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITYSTUDY OF TANDEM HIGH-DOSE CHEMOTHERAPY CYCLES WITHOUT STEM-CELL SUPPORT
Authors: MORGAN RJ DOROSHOW JH VENKATARAMAN K CHANG K RASCHKO J SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V MARGOLIN K FORMAN S AKMAN S COLUZZI P AHN C WEISS L GADGIL U HARRISON J
Citation: Rj. Morgan et al., HIGH-DOSE INFUSIONAL DOXORUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITYSTUDY OF TANDEM HIGH-DOSE CHEMOTHERAPY CYCLES WITHOUT STEM-CELL SUPPORT, Clinical cancer research, 3(12), 1997, pp. 2337-2345
PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: NEWMAN EM CARROLL M AKMAN SA CHOW W COLUZZI P HAMASAKI V LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW SHIBATA S SOMLO G TETEF M YEN Y AHN CW DOROSHOW JH
Citation: Em. Newman et al., PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 254-258
5-FLUOROURACIL AND HIGH-DOSE CALCIUM LEUCOVORIN FOR HEPATOCELLULAR-CARCINOMA - A PHASE-II TRIAL
Authors: TETEF M DOROSHOW J AKMAN S COLUZZI P LEONG L MARGOLIN K MORGAN RJ RASCHKO J SHIBATA S SOMLO G AHN C
Citation: M. Tetef et al., 5-FLUOROURACIL AND HIGH-DOSE CALCIUM LEUCOVORIN FOR HEPATOCELLULAR-CARCINOMA - A PHASE-II TRIAL, Cancer investigation, 13(5), 1995, pp. 460-463
AN INSTITUTIONAL COMMITMENT TO PAIN MANAGEMENT
Authors: FERRELL BR DEAN GE GRANT M COLUZZI P
Citation: Br. Ferrell et al., AN INSTITUTIONAL COMMITMENT TO PAIN MANAGEMENT, Journal of clinical oncology, 13(9), 1995, pp. 2158-2165
MITOMYCIN-C AND MENADIONE FOR THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCERS - A PHASE-II TRIAL
Authors: TETEF M MARGOLIN K AHN C AKMAN S CHOW W COLUZZI P LEONG L MORGAN RJ RASCHKO J SHIBATA S SOMLO G DOROSHOW JH
Citation: M. Tetef et al., MITOMYCIN-C AND MENADIONE FOR THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCERS - A PHASE-II TRIAL, Journal of cancer research and clinical oncology, 121(2), 1995, pp. 103-106
Risultati: 1-7 |